PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
173.56%
Revenue growth above 1.5x 6617.T's 35.65%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
81.63%
Gross profit growth above 1.5x 6617.T's 9.17%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
253.58%
Positive EBIT growth while 6617.T is negative. John Neff might see a substantial edge in operational management.
299.78%
Positive operating income growth while 6617.T is negative. John Neff might view this as a competitive edge in operations.
419.93%
Positive net income growth while 6617.T is negative. John Neff might see a big relative performance advantage.
419.48%
Positive EPS growth while 6617.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
419.48%
Positive diluted EPS growth while 6617.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-84.40%
Negative 10Y revenue/share CAGR while 6617.T stands at 19.69%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
14.43%
5Y revenue/share CAGR at 50-75% of 6617.T's 19.69%. Martin Whitman would worry about a lagging mid-term growth trajectory.
67.84%
3Y revenue/share CAGR above 1.5x 6617.T's 22.72%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-100.00%
Negative 10Y OCF/share CAGR while 6617.T stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
105.75%
Net income/share CAGR at 50-75% of 6617.T's 146.34%. Martin Whitman might question if the firm’s product or cost base lags behind.
-28.00%
Negative 5Y net income/share CAGR while 6617.T is 146.34%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
253.81%
Positive short-term CAGR while 6617.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
-64.77%
Negative equity/share CAGR over 10 years while 6617.T stands at 1.67%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
138.62%
5Y equity/share CAGR above 1.5x 6617.T's 1.67%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
24.93%
3Y equity/share CAGR above 1.5x 6617.T's 0.38%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
128.89%
AR growth well above 6617.T's 35.43%. Michael Burry fears inflated revenue or higher default risk in the near future.
-58.42%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.52%
Positive asset growth while 6617.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
8.07%
BV/share growth above 1.5x 6617.T's 0.54%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-4.53%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-18.56%
Our R&D shrinks while 6617.T invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
142.69%
We expand SG&A while 6617.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.